Annual EBITDA
$22.89M$9.97M+77.17%
Summary
- Current Value
- As of today, HROW annual EBITDA is $22.89M, up +77.17% on
- Historical Performance
- HROW annual EBITDA is up +450.51% over the past 3 years, and up +858.54% over the past 5 years
- All-Time High Comparison
- HROW annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HROW annual EBITDA is +317.47% above its 3-year low of $5.48M reached on an earlier date
- Sector Comparison
- HROW annual EBITDA is higher than 80.98% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $22.89M | +77.2% | +450.5% | +858.5% | +601.7% | |
| Quarterly EBITDA | $19.65M | +320.9% | +2617.2% | +750.8% | +2800.3% | |
| TTM EBITDA | $47.60M | +1079.0% | +798.7% | +2386.8% | +1758.0% | |
| Price | $46.78 | +29.4% | +238.0% | +505.2% | +94.9% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $199.61M | +53.3% | +175.4% | +290.1% | +100.0% | |
| Annual EPS | -$0.49 | +34.5% | +29.0% | -7760.9% | +95.8% | |
| Annual EBIT | $8.35M | +1340.2% | +374.1% | +3137.4% | +283.0% | |
| Annual Net Income | -$17.48M | +28.4% | +2.9% | -10000.0% | -283.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $22.89M | at high | |
| 5Y | $22.89M | at high | |
| All | $22.89M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $5.48M | N/A | +317.5% |
| 5Y | $2.83M | N/A | +708.3% |
| All | -$14.21M | +261.1% |
EBITDA History
FAQ
What is the current annual EBITDA of HROW?
As of today, HROW annual EBITDA is $22.89M
What is 1-year change in HROW annual EBITDA?
HROW annual EBITDA is up +77.17% year-over-year
What is 3-year change in HROW annual EBITDA?
HROW annual EBITDA is up +450.51% over the past 3 years
How far is HROW annual EBITDA from its all-time high?
HROW annual EBITDA is currently at its all-time high
How does HROW annual EBITDA rank versus sector peers?
HROW annual EBITDA is higher than 80.98% of companies in Healthcare sector
When is HROW next annual earnings release?
The next annual earnings release for HROW is on
Quarterly EBITDA
$19.65M$3.33M+20.43%
Summary
- Current Value
- As of today, HROW quarterly EBITDA is $19.65M, up +20.43% on
- Historical Performance
- HROW quarterly EBITDA is up +320.93% year-over-year, and up +2617.15% over the past 3 years
- All-Time High Comparison
- HROW quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HROW quarterly EBITDA is +410.64% above its 3-year low of -$6.32M reached on
- Sector Comparison
- HROW quarterly EBITDA is higher than 81.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $19.65M | +20.4% | +320.9% | +2617.2% | +750.8% | |
| Annual EBITDA | $22.89M | – | +77.2% | +450.5% | +858.5% | |
| TTM EBITDA | $47.60M | +45.9% | +1079.0% | +798.7% | +2386.8% | |
| Price | $46.78 | +15.3% | +29.4% | +238.0% | +505.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $71.64M | +12.4% | +45.4% | +213.9% | +397.5% | |
| Quarterly EPS | $0.03 | -79.6% | +122.2% | +111.1% | -91.8% | |
| Quarterly EBIT | $14.75M | +29.3% | +1016.4% | +10000.0% | +823.4% | |
| Quarterly Net Income | $1.02M | -79.6% | +124.2% | +115.8% | -88.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $19.65M | at high | |
| 3Y | $19.65M | at high | |
| 5Y | $19.65M | at high | |
| All | $19.65M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$6.32M | +410.6% | |
| 3Y | -$6.32M | +410.6% | |
| 5Y | -$6.32M | +410.6% | |
| All | -$6.32M | +410.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of HROW?
As of today, HROW quarterly EBITDA is $19.65M
What is HROW quarterly EBITDA most recent change?
HROW quarterly EBITDA was up +20.43% on September 30, 2025
What is 1-year change in HROW quarterly EBITDA?
HROW quarterly EBITDA is up +320.93% year-over-year
How far is HROW quarterly EBITDA from its all-time high?
HROW quarterly EBITDA is currently at its all-time high
How does HROW quarterly EBITDA rank versus sector peers?
HROW quarterly EBITDA is higher than 81.19% of companies in Healthcare sector
When is HROW next earnings release?
The next earnings release for HROW is on
TTM EBITDA
$47.60M$14.98M+45.92%
Summary
- Current Value
- As of today, HROW TTM EBITDA is $47.60M, up +45.92% on
- Historical Performance
- HROW TTM EBITDA is up +1079.02% year-over-year, and up +798.73% over the past 3 years
- All-Time High Comparison
- HROW TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HROW TTM EBITDA is +1079.02% above its 3-year low of $4.04M reached on
- Sector Comparison
- HROW TTM EBITDA is higher than 81.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $47.60M | +45.9% | +1079.0% | +798.7% | +2386.8% | |
| Annual EBITDA | $22.89M | – | +77.2% | +450.5% | +858.5% | |
| Quarterly EBITDA | $19.65M | +20.4% | +320.9% | +2617.2% | +750.8% | |
| Price | $46.78 | +15.3% | +29.4% | +238.0% | +505.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $250.04M | +9.8% | +47.8% | +182.7% | +433.4% | |
| TTM EPS | -$0.15 | +48.7% | +83.8% | +81.7% | -78.6% | |
| TTM EBIT | $28.08M | +91.7% | +427.5% | +1243.3% | +3301.4% | |
| TTM Net Income | -$4.99M | +51.2% | +85.1% | +77.9% | -153.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $47.60M | at high | |
| 3Y | $47.60M | at high | |
| 5Y | $47.60M | at high | |
| All | $47.60M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $21.04M | +126.3% | |
| 3Y | $4.04M | +1079.0% | |
| 5Y | $1.42M | +3249.5% | |
| All | -$15.65M | +404.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of HROW?
As of today, HROW TTM EBITDA is $47.60M
What is HROW TTM EBITDA most recent change?
HROW TTM EBITDA was up +45.92% on September 30, 2025
What is 1-year change in HROW TTM EBITDA?
HROW TTM EBITDA is up +1079.02% year-over-year
How far is HROW TTM EBITDA from its all-time high?
HROW TTM EBITDA is currently at its all-time high
How does HROW TTM EBITDA rank versus sector peers?
HROW TTM EBITDA is higher than 81.10% of companies in Healthcare sector
When is HROW next earnings release?
The next earnings release for HROW is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- HROW Official Website www.harrow.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1360214/000149315225021562/0001493152-25-021562-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1360214/000164117225000925/0001641172-25-000925-index.htm
- HROW Profile on Yahoo Finance finance.yahoo.com/quote/HROW
- HROW Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hrow